Uzawa Narikazu, Suzuki Miho, Miura Chika, Tomomatsu Nobuyoshi, Izumo Toshiyuki, Harada Kiyoshi
Maxillofacial Surgery, Department of Maxillofacial Reconstruction and Function, Division of Maxillofacial and Neck Reconstruction, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan.
Diagnostic Oral Pathology, Division of Oral Health Science, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8549, Japan.
Oncol Lett. 2015 Jan;9(1):459-467. doi: 10.3892/ol.2014.2654. Epub 2014 Oct 31.
Ameloblastic carcinoma (AC) is a rare malignant odontogenic neoplasm that tends to occur in the mandible rather than in the maxilla. This malignancy is classified as a tumor that combines the morphological features of ameloblastoma and carcinoma, regardless of the presence or absence of metastasis. In addition, AC has been classified into two types, primary and secondary. The former develops and the latter develops by malignant transformation of a pre-existing benign ameloblastoma. The present study describes the case of a 22-year-old patient with primary AC of the maxilla. A review of the literature focusing on the clinical details, treatment results and histopathological and phenotypic information available for ameloblastic carcinoma of the maxilla from a 60-year period was also performed. As a result, it was found that primary AC is dominant in the maxilla and does not exhibit an aggressive phenotype compared with secondary AC. In addition, the presence of recurrence was found to correlate with mortality, indicating that early, aggressive and complete removal of the tumor is the best treatment for survival.
成釉细胞癌(AC)是一种罕见的恶性牙源性肿瘤,多发生于下颌骨而非上颌骨。这种恶性肿瘤被归类为一种兼具成釉细胞瘤和癌形态学特征的肿瘤,无论有无转移。此外,AC可分为原发性和继发性两种类型。前者为原发性发生,后者由先前存在的良性成釉细胞瘤恶变而来。本研究描述了一名22岁上颌骨原发性AC患者的病例。还对60年间上颌骨成釉细胞癌的临床细节、治疗结果以及组织病理学和表型信息进行了文献综述。结果发现,原发性AC在上颌骨中占主导地位,与继发性AC相比,不表现出侵袭性表型。此外,发现复发的存在与死亡率相关,这表明早期、积极和彻底切除肿瘤是生存的最佳治疗方法。